Baroda BNP Paribas Health and Wellness Fund vs HDFC Pharma and Healthcare Fund

Baroda BNP vs HDFC· Portfolio Overlap Analysis

46.7%High Overlap
13 common stocksRank #13693 / 20,000

Investor takeaway: At 46.7% overlap, a significant part of these portfolios is identical. Despite coming from different AMCs, the stock picks still converge heavily. Make sure both funds actually serve different jobs in your allocation.

Common Holdings (13)

StockWt% in Baroda BNP Paribas Health and Wt% in HDFC Pharma and HealthcareOverlap
Sun Pharmaceutical Industries Limited
Pharmaceuticals & Biotechnology
9.23%9.81%9.23%
Max Healthcare Institute Limited
Healthcare Services
6.38%6.36%6.36%
Lupin Limited
Pharmaceuticals & Biotechnology
5.71%6.44%5.71%
Aster DM Healthcare Limited
Healthcare Services
5.22%5.42%5.22%
Fortis Healthcare Limited
Healthcare Services
4.59%4.02%4.02%
IPCA Laboratories Limited
Pharmaceuticals & Biotechnology
3.95%4.80%3.95%
Laurus Labs Limited
Pharmaceuticals & Biotechnology
4.09%2.91%2.91%
Torrent Pharmaceuticals Limited
Pharmaceuticals & Biotechnology
4.99%2.34%2.34%
Divi's Laboratories Limited
Pharmaceuticals & Biotechnology
1.92%8.38%1.92%
Dr. Lal Path Labs Limited
Healthcare Services
2.48%1.63%1.63%
Acutaas Chemicals Limited
Pharmaceuticals & Biotechnology
1.34%3.60%1.34%
Gland Pharma Limited
Pharmaceuticals & Biotechnology
3.09%1.12%1.12%
Metropolis Healthcare Limited
Healthcare Services
0.96%2.53%0.96%

Unique to Baroda BNP Paribas Health and

  • Abbott India Limited4.60%
  • Apollo Hospitals Enterprise Limited4.15%
  • AstraZeneca Pharma India Limited4.07%

Unique to HDFC Pharma and Healthcare

  • Glenmark Pharmaceuticals Ltd.6.62%
  • Alkem Laboratories Ltd.6.21%
  • Anthem Biosciences Limited4.46%

Sector Overlap Breakdown

Pharmaceuticals & Biotechnology
28.5% (8)
Healthcare Services
18.2% (5)

More comparisons for Baroda BNP Paribas Health and

More comparisons for HDFC Pharma and Healthcare

Overlap calculated on equity holdings only. Debt, government securities, and cash are excluded.